Jovana Panic | Biomedical engineering | Best Researcher Award

Dr. Jovana Panic | Biomedical engineering | Best Researcher Award

Dr. Jovana Panic, Osaka University, Japan

Dr. Jovana Panic is a Postdoctoral Researcher at the Institute of Datability Science, Osaka University, Japan. Born on November 14, 1994, she specializes in biomedical engineering, artificial intelligence, and medical image analysis. With strong intercultural skills developed through volunteering and theater experiences, she is a multilingual collaborator fluent in Italian, English, Serbian, and Japanese. She holds a Ph.D. in Bioengineering and Surgical Sciences from the Polytechnic University of Turin. Her work focuses on AI-driven solutions for medical imaging, particularly retinal and oncological applications. Dr. Panic is passionate about merging technology and healthcare for precision diagnostics. ๐ŸŒ๐Ÿง ๐Ÿ“Š

Publication Profile

Google Scholar

๐ŸŽ“ Education

Dr. Panic earned her Ph.D. in Bioengineering and Medical-Surgical Sciences from the Polytechnic University of Turin and the University of Turin in March 2024 with an โ€œExcellentโ€ grade. Her research focused on AI-driven MRI systems for cancer detection. She holds a Masterโ€™s degree in Biomedical Engineering (2019) with a grade of 109/110, and a Bachelor’s degree in Biomedical Engineering (2016) with 100/110, both from the Polytechnic University of Turin. Her academic background includes biomedical signal processing, clinical informatics, and bioimaging. She completed high school at Scientific High School โ€œCarlo Cattaneo,โ€ Turin, in 2013 with a score of 93/100. ๐ŸŽ“๐Ÿ“˜๐Ÿ”ฌ

๐Ÿ’ผ Experience

Dr. Panic began her postdoctoral role at Osaka University in April 2024, working on AI systems for retinal fundus image analysis. From 2020 to 2024, she was a Ph.D. student and teaching assistant in AI and biomedical engineering at the Polytechnic and University of Turin. She contributed to research at the Candiolo Cancer Institute, developing AI models for rectal and prostate cancer MRI analysis. Her earlier experiences include a research fellowship (2019โ€“2020), clinical engineering at Cellini Humanitas Hospital, and a masterโ€™s thesis on DL-based segmentation of rectal cancer. Her multidisciplinary roles demonstrate her commitment to medical AI innovation. ๐Ÿฅ๐Ÿ–ฅ๏ธ๐Ÿ“ˆ

๐Ÿ… Awards & Honors

Dr. Panic has been involved in multiple prestigious European and national research projects, including AIRC, Horizon 2020, and Ministry of Health grants. These projects supported her work in AI-based segmentation, response prediction, and virtual biopsy systems for rectal and prostate cancers. Her Ph.D. research received an โ€œExcellentโ€ grade, recognizing her contributions to oncological imaging. She also served as a teaching assistant in graduate and medical programs, reflecting academic trust in her expertise. Additionally, she received internship and research fellow opportunities at leading institutions like the Candiolo Cancer Institute and Humanitas Hospital, underscoring her promising research trajectory. ๐Ÿง ๐Ÿ†๐Ÿ“š

๐Ÿ”ฌ Research Focus

Dr. Panicโ€™s research integrates artificial intelligence and biomedical imaging for clinical applications. Her primary focus is on radiomics and deep learning algorithms for automated cancer detection and characterization in MRI and retinal images. She developed convolutional neural networks (CNNs) for rectal and prostate cancer analysis and is currently exploring AI-based retinal fundus image systems. Her work spans radiology, surgical sciences, and data science, aiming to enhance diagnostic precision through AI-powered clinical decision tools. Through her interdisciplinary research, she bridges computer science and medicine to revolutionize cancer imaging and eye disease diagnostics. ๐Ÿงฌ๐Ÿ’ป๐Ÿฉบ

Publication Top Notes

  • ๐Ÿง ๐Ÿ“Š Radiomics and MRI of rectal cancer: from engineering to clinical practice โ€“ 51 citations, 2021

  • ๐Ÿงฌ๐Ÿค– MRI-based radiomics to predict response in rectal cancer: manual vs automatic segmentation โ€“ 28 citations, 2022

  • ๐Ÿง ๐Ÿ“ˆ CNN-based system for colorectal cancer segmentation on MRI โ€“ 23 citations, 2020

  • ๐Ÿ’‰๐Ÿงฎ Radiomics to predict chemo response in liver metastases (CT images) โ€“ 15 citations, 2020

  • ๐Ÿ“Š๐Ÿฅ Normalization strategies in multi-center abdominal MRI radiomics: review/meta-analysis โ€“ 12 citations, 2023

  • ๐Ÿงชโš™๏ธ Normalization improving robustness of MRI radiomics โ€“ 9 citations, 2023

  • ๐Ÿงฌ๐Ÿ’Š Predicting resistance to 1st line chemo in liver metastatic colorectal cancer โ€“ 9 citations, 2021

  • ๐Ÿ”๐Ÿง  Deep learning for prostate segmentation on T2w MRI โ€“ 7 citations, 2021

  • ๐Ÿฉป๐Ÿ”ฌ Virtual biopsy in abdominal pathology: current status โ€“ 6 citations, 2023

  • ๐Ÿค–๐Ÿง  Fully automatic DL segmentation of rectal cancer (multi-center) โ€“ 6 citations, 2022

Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Dr. Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Dr. Victor Chigozie, David Umahi Federal University of Health Sciences, Nigeria

Dr. Chigozie Victor Uchenna is a Lecturer I at David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria, where he also serves as the acting head of the Department of Pharmaceutical Microbiology and Biotechnology. He completed his Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, where his research focused on the identification and bioactivities of secondary metabolites from fungi. Dr. Chigozie has extensive teaching and research experience, including in pharmaceutical microbiology, biotechnology, and the study of natural products. His key research areas include bioactive compounds, antimicrobial agents, and cancer therapeutics.

Publication Profile

Orcid

Google Scholar

Educational Background ๐ŸŽ“

Dr. Victor Chigozie holds a Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, Nigeria, where his research focused on the identification and bioactivities of secondary metabolites from Aspergillus species and Daldinia eschscholtzii found in Mangifera indica and Musa paradisiaca leaves. He graduated with first-class honors (4.69/5.0) in 2021. Dr. Chigozie also completed an M.Sc. in Pharmaceutical Microbiology and Biotechnology at the same university, with research on the quality assessment of tetanus toxoid brands in southeastern Nigeria’s markets, publishing his findings. He holds a B.Sc. in Applied Microbiology with second-class honors (4.12/5.0) and a Senior School Certificate with Upper Credit. ๐ŸŽ“๐Ÿ“š๐Ÿ”ฌ

 

Professional Experience ๐Ÿง‘โ€๐Ÿ”ฌ

Dr. Victor Chigozie has held several key positions in academic and government institutions, contributing significantly to research and development. As a Lecturer I and Acting Head of Pharmaceutical Microbiology and Biotechnology at David Umahi Federal University of Health Sciences, Ebonyi State, he has been instrumental in coordinating classes, practicals, and research, especially in natural products and pharmaceutical biotechnology. He set up a BSL-2 lab and contributed to the development of practical manuals.

Teaching Experience ๐Ÿ“š๐Ÿ‘จโ€๐Ÿซ

Dr. Victor Chigozie has a rich teaching history, contributing extensively to pharmaceutical sciences. At David Umahi Federal University of Health Sciences, Uburu, he has taught several courses, including Introductory Pharmaceutical Microbiology (PHM 201) and Molecular Biology (PHM 202) since 2022, alongside practicals in both subjects. His expertise extends to Pharmaceutical Microbiology I (PHM 301), Aseptic Processes and Sterilization Technology (PHM 302), and Bioinformatics, Pharmacogenetics, and Pharmacogenomics (PHM 382), all of which he began teaching in 2024. Additionally, he teaches courses on integrated pharmacotherapy and sterile product technology.

 

Awards and Recognitions ๐Ÿ†๐ŸŽ–๏ธ

Dr. Victor Chigozie has received numerous prestigious awards for his contributions to pharmaceutical microbiology and biotechnology. Notably, he was named Top Cite Author by Wiley Publishers for 2022-2023. He also received a Travel Grant Award from the Wuhan Institute of Virology (2023) and the National Foundation for Infectious Diseases (2012). Dr. Chigozie was honored with the Ph.D. Award for being the top of his class at Nnamdi Azikiwe University (2021). Additionally, he won the CBN-NYSC-NDE Venture Prize Competition during his NYSC service for the Best Business Proposal (2010). ๐Ÿ…๐Ÿ“š

 

Research Focus

 

Dr. Victor Chigozieโ€™s research spans a wide array of topics in pharmaceutical microbiology, biotechnology, and public health. His work includes antibiotic resistance, exploring emerging strategies to tackle global health challenges. He has contributed significantly to bioactive compounds and endophytic fungi, studying their potential in antimicrobial, anti-inflammatory, and analgesic activities. His research also delves into pharmacovigilance, self-medication practices, and the role of community pharmacies in healthcare systems. Additionally, Dr. Chigozie investigates biosecurity, biosafety, and differentiated care models for diseases like HIV/AIDS. His focus on indigenous knowledge in managing emerging infectious diseases in Africa highlights his commitment to improving health through both modern science and traditional insights. ๐ŸŒฑ๐Ÿ’Š

 

Publication Top Notes

  • Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace โ€“ D Chinemerem Nwobodo, MC Ugwu, C Oliseloke Anie, MTS Alโ€Ouqaili, … (Cited by: 405, Year: 2022) ๐Ÿฆ 
  • Evaluation of the analgesic, anti-inflammatory and antimicrobial activities of leaf extracts of Breynia nivosa โ€“ FA Onyegbule, IO Ilouno, PM Eze, CC Abba, VU Chigozie (Cited by: 19, Year: 2014) ๐ŸŒฟ
  • Isolation, identification, and evaluation of biological activities of Daldinia eschscholtzii, an endophytic fungus isolated from the leaves of Musa paradisiaca โ€“ V Chigozie, M Okezie, E Ajaegbu, F Okoye, C Esimone (Cited by: 13, Year: 2020) ๐ŸŒ
  • Bioactivities and HPLC analysis of secondary metabolites of a morphologically identified endophytic Aspergillus fungus isolated from Mangifera indica โ€“ VU Chigozie, MU Okezie, EE Ajaegbu, FB Okoye, CO Esimone (Cited by: 11, Year: 2022) ๐Ÿฅญ
  • Larvicidal and synergistic potentials of some plant extracts against Aedes aegypti โ€“ GT Onah, EE Ajaegbu, CC Ezeagha, VU Chigozie, AM Bello, P Chinelo (Cited by: 3, Year: 2022) ๐ŸฆŸ
  • Practice, Risk Perception, and Correlates of Self-Medication Among Pregnant Women in Awka โ€“ OOB Anthony Maduka, Daniel U. Eze, Victor U. Chigozie (Cited by: 2, Year: 2024) ๐Ÿ’Š
  • Community Pharmacies, Extent of Services, and Preparedness for Primary Health Care Policy Implementation in Nigeria from 1980 to 2022: A Narrative Review โ€“ M Maureen, DU Eze, OC Clementina, N Monica, VU Chigozie, O Brian O (Cited by: 1, Year: 2024) ๐Ÿฅ
  • Quality Assessment of Some Brands of Tetanus Toxoids Marketed in Open Markets in South-Eastern Nigeria โ€“ VU Chigozie, PM Eze, CR Chukwunwejim, CC Abba, CS Nworu, … (Cited by: 1, Year: 2014) ๐Ÿ’‰
  • Identification of Some Bioactive Compounds from Camellia sinensis as Possible Inhibitors of human epidermal growth factor receptor 2 (HER2) โ€“ LN Ebenyi, CBG Egwuom, EM Halilu, AP Obialor, TO Johnson, … (Year: 2024) ๐Ÿต
  • Antioxidative, anti-androgenic, and inhibitory activities of ethanolic extract of Annona muricata leaf on sex hormones-induced benign prostate hyperplasia through in vivo and … โ€“ DDCBA Lilian N. Ebenyi, Victor U. Chigozie (Year: 2024) ๐Ÿƒ